Surrozen Statistics
NASDAQ: SRZNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
28.46-2.21 (-7.21%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Surrozen by the numbers
Surrozen has a market capitalization of $596.4 million based on 20.96M shares outstanding. With trailing EPS of $-41.94, Surrozen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.7% above its 50-day average and 10.1% above its 200-day average.
Average daily trading volume is 537.16K shares, or about $15.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SRZN valuation vs. peer median
| Metric | SRZN | Peer median | Difference |
|---|---|---|---|
| Market cap | $596.40M | $576.95M | +3% |
| Avg. volume | 537.16K | 637.10K | -16% |
Peer median across 8 companies: CGEM, FDMT, ENTX, IAM, DBVT, ETRA, ATTO, SLDB.
Valuation
- Market cap
- $596.40M
- Price / sales (latest FY)
- 171.53
- EPS (TTM)
- $-41.94
- Shares outstanding
- 20.96M
Price and trading
- Previous close
- 30.67
- Open
- 29.92
- Day range
- 28.25 – 30.34
- 52-week range
- 12.79 – 37.83
- 52-week change
- +115.61%
- Beta
- —
- Volume
- 148.85K
- Average volume
- 537.16K
Dividends and events
- Annual dividend
- None
- Next earnings date
- May 9, 2025
Additional statistics
- Market Cap
- 596.40M
- Forward Pe
- -6.04
- Eps
- -41.94
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 37.83
- Week52 Low
- 12.79
- Avg Volume
- 537.16K
- Shares Outstanding
- 20.96M
- Ma50
- 26.93
- Ma200
- 25.84
- Earnings Date
- May 9, 2025
- Pct From52w High
- -24.77%
- Pct From52w Low
- 122.53%